KR910004659A - 약물학적 활성을 지닌 펩티드 유도체들 및 이들을 함유하는 제약학적 제제 - Google Patents

약물학적 활성을 지닌 펩티드 유도체들 및 이들을 함유하는 제약학적 제제 Download PDF

Info

Publication number
KR910004659A
KR910004659A KR1019900013264A KR900013264A KR910004659A KR 910004659 A KR910004659 A KR 910004659A KR 1019900013264 A KR1019900013264 A KR 1019900013264A KR 900013264 A KR900013264 A KR 900013264A KR 910004659 A KR910004659 A KR 910004659A
Authority
KR
South Korea
Prior art keywords
asp
thr
tyr
compound
alkyl
Prior art date
Application number
KR1019900013264A
Other languages
English (en)
Inventor
브루체세 띠베리오
시뇨리니 마써모
갈로 판치아노 알베르또
떼르미니 로베르타
Original Assignee
알폰소 지암브로코노
스파 소시에타' 프로도리 안티비오티시 에스.피.에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알폰소 지암브로코노, 스파 소시에타' 프로도리 안티비오티시 에스.피.에이 filed Critical 알폰소 지암브로코노
Publication of KR910004659A publication Critical patent/KR910004659A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음.

Description

약물학적 활성을 지닌 펩티드 유도체들 및 이들을 함유하는 제약학적 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 다음 일반식을 갖는 펩티드 유도체 및 이들의 제약학적으로 허용가능한 산 또는 염기로의 염.
    식중, R은 -H, C1-3알킬, C1-3아실, C1-4알킬이 있는 알콕시카보닐; R1은 H, C1-3알킬; R2는 R′2가 C1-3알킬, C1-3아실, 벤질인 -OR′2, -OH, -H; R3는 -H, -CH2; n은 1, 2; R4는 R′4가 C1-3알킬, 벤질인 -COOR′4, -CONH2, -COOH, -H; R5는 R′5가 C1-3알킬, C1-3아실, 벤질인 -OR′5, 3, 4-OH, 4-OH, -H; R6는 R′6,가 C1-3알킬, 벤질인 -OR′6, -NH2, -OH, 단 R=H, R1=H, R2=-OH, R2=-CN3, n=1, R4=-COOH, R5=-OH, R6=-OH 일때 이들중 최소한 하나가 D-형이거나 또는 전체적으로 또는 부분적으로 라세미인 조건을 만족한다면 별표시를 한 비대칭 탄소원자는 L- 또는 D-형, 또는 전체적으로 또는 부분적으로 라세미이다.
  2. 제1항에 있어서, H-Thr-Asp-D-Tyr-OH, H-Thr-D-Asp-Tyr-OH, H-D-Thr-Asp-Tyr-OH, H-D-Thr-D-Asp-Tyr-OH, H-Thr-D-Asp-D-Tyr-OH, H-D-Thr-Asp-D-Tyr-OH, H-D-Thr-D-Asp-D-Asp-D-Tyr-OH, H-DL-Thr-Asp-Tyr-OH, H-Thr-Asp-DL-Tyr-OH인 화합물.
  3. 제1항에 있어서, Ac-Thr-Asp-Tyr-OH인 화합물.
  4. 제1항에 있어서, Boc-Thr-Asp-Tyr-OH인 화합물.
  5. 제1항에 있어서, H-Ser-Asp-Tyr-OH인 화합물.
  6. 제1항에 있어서, H-Thr-Glu-Tyr-OH인 화합물.
  7. 제1항에 있어서, H-Ala-Asp-Tyr-OH인 화합물.
  8. 제1항에 있어서, H-Thr-Asp-Tyr-OH인 화합물.
  9. 제1항에 있어서, H-Thr-Asp-DOPA-OH인 화합물.
  10. 제1항에 있어서, H-Thr-Asp(OMe)-Thr-OH, H-Thr-Asp-Tyr-OMe, H-Thr-Asp(OMe)-Tyr-OMe, Me2-Thr-Asp-Tyr-OH, H-Thr-Asp-Tyr-NH2, H-Thr-Asp-Tyr(Me)-OH인 화합물.
  11. 최소한 하나의 제1항의 화합물을 함유하는 진통효과, 항비루스성 또는 면역 조정력을 지닌 제약학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900013264A 1989-08-28 1990-08-28 약물학적 활성을 지닌 펩티드 유도체들 및 이들을 함유하는 제약학적 제제 KR910004659A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21567A/89 1989-08-28
IT8921567A IT1231342B (it) 1989-08-28 1989-08-28 Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
KR910004659A true KR910004659A (ko) 1991-03-29

Family

ID=11183718

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900013264A KR910004659A (ko) 1989-08-28 1990-08-28 약물학적 활성을 지닌 펩티드 유도체들 및 이들을 함유하는 제약학적 제제

Country Status (8)

Country Link
US (1) US5182265A (ko)
EP (1) EP0421074B1 (ko)
JP (1) JPH0390098A (ko)
KR (1) KR910004659A (ko)
DE (1) DE69018914T2 (ko)
ES (1) ES2071710T3 (ko)
IT (1) IT1231342B (ko)
PT (1) PT95112B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02001349A (es) * 1999-08-09 2002-07-22 Tripep Ab Inhibidores de la polimerizacion de proteinas y metodos de uso.
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
US7371809B2 (en) 2000-02-07 2008-05-13 Wisconsin Alumni Research Foundation Pharmacologically active antiviral peptides
US6593455B2 (en) 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
EP1436317A1 (en) 2001-09-19 2004-07-14 Tripep Ab Molecules that block viral infectivity and methods of use thereof
WO2005060541A2 (en) * 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection
KR200447742Y1 (ko) * 2009-07-10 2010-02-12 조용진 법단

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063727A (en) * 1965-04-12 1967-03-30 Ici Ltd Amide derivatives
GB1465235A (en) * 1975-04-29 1977-02-23 Sagami Chem Res Process for preparing peptides
GB8322414D0 (en) * 1983-08-19 1983-09-21 Szelke M Renin inhibitors
JPS61148198A (ja) * 1984-12-22 1986-07-05 Ajinomoto Co Inc 新規トリペプチド化合物および甘味剤
IT1190433B (it) * 1985-12-11 1988-02-16 Prodotti Antibiotici Spa Peptidi correlati al lisozima

Also Published As

Publication number Publication date
PT95112B (pt) 1997-04-30
IT8921567A0 (it) 1989-08-28
US5182265A (en) 1993-01-26
PT95112A (pt) 1991-04-18
DE69018914T2 (de) 1995-11-16
EP0421074B1 (en) 1995-04-26
IT1231342B (it) 1991-11-28
EP0421074A1 (en) 1991-04-10
ES2071710T3 (es) 1995-07-01
DE69018914D1 (de) 1995-06-01
JPH0390098A (ja) 1991-04-16

Similar Documents

Publication Publication Date Title
KR900018073A (ko) 피페라진 화합물
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
DK0618898T3 (da) Amidinoderivater
KR920012040A (ko) 신규의 디히드로-이소퀴놀린 유도체
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
KR960007545A (ko) 합성 흥분성 아미노산
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
KR870003974A (ko) 비시클로 치환된 페닐아세토니트릴 유도체
KR870005637A (ko) 약물 데포
AU4271093A (en) Oxazolidine derivative and pharmaceutically acceptable salt thereof
KR860006464A (ko) 6-티오크산틴 유도체
KR910004659A (ko) 약물학적 활성을 지닌 펩티드 유도체들 및 이들을 함유하는 제약학적 제제
FI921522A0 (fi) Pyrazolopyridinfoerening och foerfarande foer dess framstaellning.
RU2059603C1 (ru) ПРОИЗВОДНЫЕ α -ЗАМЕЩЕННЫХ АРИЛУКСУСНЫХ КИСЛОТ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
SE8600017L (sv) Ny forening
SE7602869L (sv) Para-(aryl(alkyl eller alkenyl)-amino)-bensoesyraderivat samt forfarande for framstellning derav
CA1324762C (en) 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
KR900018048A (ko) 환 치환된 2-아미노-1,2,3,4-테트라하이드로나프탈렌
FI924285A (fi) 4-desoxi-4-epipodophyllotoxinderivat eller ett farmaceutiskt acceptabelt salt daerav
KR900009606A (ko) 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
ATE150028T1 (de) Neue ganglioside-derivaten
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
DK0388049T3 (da) Penciclovirderivater til behandling af hepatitis B infektioner

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid